Skip to main content

Illumina statistics

  • ILMN · Nasdaq
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$198.26−4.22%Close 16 Nov 2026 · Market value $30.43B

Valuation and share-price figures are struck on the latest close (16 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Illumina is valued at $30.43B on its latest close. Its price is 34.0 times its earnings.

Market value$30.43B
Enterprise value$30.95B
Price / earnings34.00
Price / sales6.71
Price / book9.68
EV / EBITDA25.02
EV / sales6.82
Price / free cash flow28.79
Price / free cash flow, own 5-year average108.33
EV / EBIT32.72
EV / free cash flow29.71
Free cash flow yield3.5%

Share price

Latest close$198.26
Day's change−4.2%
52-week high$309.35
52-week low$112.65
From 52-week high−35.9%
Return · 1 month−24.5%
Return · 3 months−9.6%
Return · year to date+51.2%
Return · 1 year+65.3%
Beta · 1 year against the S&P 5001.10
50-day average$248.62
200-day average$179.78
RSI 1432.3
Average volume · 20 sessions2.1M

Margins and returns

For fiscal 2025, as filed.

Gross margin66.1%
Operating margin18.6%
Net margin19.6%
Free cash flow margin21.4%
Return on equity33.4%
Return on assets9.8%
Return on invested capital14.6%
Return on invested capital, 5-year average−7.3%
Return on capital employed16.4%
Stock-based compensation / revenue6.3%

Financial position

At the end of fiscal 2025.

Cash and equivalents$1.42B
Total debt$2.55B
Net debt$920.0M
Current ratio2.08
Quick ratio1.79
Debt / equity0.94
Net debt / EBITDA0.85
Interest coverage7.99

Growth

Revenue, latest quarter on a year+4.2%
Revenue, twelve months on a year+5.8%
EPS, latest quarter on a year+45.9%
EPS, twelve months on a year+30.5%
Revenue, 5-year compound+6.1%
Revenue, 10-year compound+7.0%
Net income, 5-year compound+5.3%
Free cash flow, 5-year compound+0.9%
EPS, 5-year compound+4.2%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares156M
Shares outstanding, 5-year compound+1.1%
Net share repurchases$698.0M

Taxes

For fiscal 2025, as filed.

Income tax expense$236.0M
Effective tax rate21.7%

ILMN in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.